Clinical Trials on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH in United States
Total 180 results
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Aligos TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated SteatohepatitisUnited States
-
89bio, Inc.RecruitingMetabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With FibrosisUnited States
-
Grand Valley State UniversityEnrolling by invitationMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)United States
-
Regeneron PharmaceuticalsRecruitingNon-alcoholic Steatohepatitis (NASH) | Metabolic Dysfunction Associated Steatohepatitis (MASH)United States, Korea, Republic of, Puerto Rico, Japan
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Milton S. Hershey Medical CenterRecruitingExercise | NASH - Nonalcoholic Steatohepatitis | NASH | LiverUnited States
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
University of Illinois at ChicagoTerminatedNonalcoholic Steatohepatitis (NASH) | Hepatic SteatosisUnited States
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Metacrine, Inc.Completed
-
Massachusetts General HospitalRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Navidea BiopharmaceuticalsCompletedNonalcoholic Steatohepatitis | NASH - Nonalcoholic SteatohepatitisUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Duke UniversityCompletedLiver Diseases | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University of California, San FranciscoCompleted
-
Hepagene (Shanghai) Co., Ltd.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Rivus Pharmaceuticals, Inc.Completed
-
PerspectumRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Mayo ClinicRecruiting
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Lipocine Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
CymaBay Therapeutics, Inc.TerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
CytoDyn, Inc.Amarex Clinical ResearchCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Cascade Pharmaceuticals, IncLaboratory Corporation of AmericaCompletedNonalcoholic Steatohepatitis (NASH)United States
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Corcept TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
HepQuant, LLCTerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
Lipocine Inc.CompletedNonalcoholic Steatohepatitis (NASH)United States
-
National Institute of Diabetes and Digestive and...CompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited Kingdom
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Terns, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Terns, Inc.Completed